CureVac GSK Experimental COVID‑19 Variant Vaccine Efficacy Demonstrated in Mice—New Study
CureVac, GSK's experimental Covid-19 variant vaccine effective in mice: Study, World News,FRANKFURT — CureVac and GSK's second-generation vaccine candidate targeting two recent Covid-19 variants has been shown to be highly effective in preclinical studies on mice, CureVac said, as it seeks
